• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Apr3
Virpax Pharmaceuticals Receives NASDAQ Delisting Notice for Not Meeting Shareholder Equity Requirements, Stock Down 87.16% Year-to-Date
15:32
Mar25
Virpax Pharmaceuticals Submits Application to Issue Up to 2.4 Million Shares of Common Stock
11:52
Mar18
Virpax Pharmaceuticals Inc Receives Positive Results from PROBUDUR™ Dosage Range Study
21:37
Mar4
Virpax Pharmaceuticals released FY2024 annual earnings on March 3, 2025 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -70.9102 USD (forecast -82.5 USD)
04:00
Virpax Pharmaceuticals released FY2024 Q4 earnings on March 3, 2025 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -9.1781 USD (forecast -6.75 USD)
04:00
Jan28
Virpax Pharmaceuticals Announces Public Offering at $0.20 per Share, Stock Nears 52-Week Low
15:31

Schedules & Filings

Schedules
Filings
Mar21
Reverse Stock Split(EST)

1-for-25 Reverse Stock Split

Mar3
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Net Income -3.39 M, EPS -9.1781

Nov14
Earning Release(EST)

FY2024 Q3 Earning Release (USD) Net Income -2.006 M, EPS -10.7695

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MNDR
3.040
+83.13%
+1.380
SOND
0.1650
+79.15%
+0.073
EPSM
3.660
+66.36%
+1.460
VSA
0.2785
+59.05%
+0.103
PACS
26.140
+55.32%
+9.310
AIIO
0.7800
+41.77%
+0.230
LUD
9.620
+39.42%
+2.720
RDACR
0.2510
+32.11%
+0.061
PLAG
2.980
+31.28%
+0.710
IONZ
6.420
+28.40%
+1.420
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy